IP Library Granted Patent US 12,448,615
Granted Patent B2
US 12,448,615 · App. 17/559,782 · Granted Oct 21, 2025

Method of purifying and isolating collagenase

Inventors: Christine A Sheaffer (Doylestown, PA); Michael Berbaum (Pottstown, PA); John Hanna (East Norriton, PA); Jason Dziadosz (Quakertown, PA); Daniel Shanafelt (Red Hill, PA)
Assignee: Endo Operations Limited
C12N9/52C12Y304/24003A61K31/00A61K38/00G01N33/56911
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,448,615
App. No.
17/559,782
Granted
Oct 21, 2025
Kind
B2
Abstract

The present invention relates to the fields of collagenase production and collagenase products, and particularly to improving the reproducibility, purity, and stability of collagenase I and collagenase II compositions, where the compositions are pure to at least 95% by area as measured by reverse phase high pressure liquid chromatography (RP-HPLC) and essentially free of neutral protease.

Claims (18)

1. A method of purifying collagenase I and collagenase II, the method comprising:

treating the collagenase I and collagenase II with a salt selected from ammonium sulfate, sodium chloride, potassium chloride, sodium sulfate, and mixtures thereof and forming a collagenase I and collagenase II solution, wherein the salt comprises less than about 1.2 ppm of nickel and less than about 84.4 ppm of zinc;

fractionating the collagenase I and collagenase II solution using chromatography; and

separating a plurality of highly pure fractions of the collagenase I and a plurality of highly pure fractions of collagenase II from fractions of neutral protease, and

mixing the highly pure fractions of the collagenase I and the highly pure fractions of the collagenase II, wherein the mixture has less than 50 ng neutral protease per mg of the collagenase mixture, to thereby purify the collagenase.

2. The method of claim 1 , wherein the salt further comprises low levels of metals selected from aluminum, arsenic, calcium, cadmium, chromium, copper, iron, magnesium, and lead.

3. The method of claim 1 , wherein the salt comprises nickel in an amount of less than about 1.0 ppm, less than about 0.9 ppm, less than about 0.8 ppm, less than about 0.7 ppm, less than about 0.6 ppm, less than about 0.5 ppm, less than about 0.4 ppm, less than about 0.3 ppm, less than about 0.2 ppm, less than about 0.1 ppm, less than about 0.09 ppm, less than about 0.08 ppm, less than about 0.07 ppm, less than about 0.06 ppm, less than about 0.05 ppm, less than about 0.04 ppm, less than about 0.03 ppm, less than about 0.02 ppm, or less than about 0.01 ppm.

4. The method of claim 1 , wherein the salt comprises zinc in an amount of less than about 80 ppm, less than about 50 ppm, less than about 25 ppm, less than about 10 ppm, less than about 5 ppm, less than about 3 ppm, or less than about 1 ppm.

5. The method of claim 2 , wherein the salt comprises less than about 0.75 ppm aluminum, less than about 0.2 ppm arsenic, less than about 10 ppm calcium, less than about 1 ppm cadmium, less than about 0.75 ppm chromium, less than about 1 ppm copper, less than about 2 ppm iron, less than about 5 ppm magnesium, or less than about 2 ppm lead.

6. The method of claim 1 , wherein the separating step comprises testing each fraction of the collagenase on an SDS-PAGE gel and pooling only fractions of the collagenase that are free from detectable amounts of neutral protease on the gel.

7. The method of claim 1 , wherein the purified collagenase I and collagenase II is free from detectable amounts of neutral protease.

8. The method of claim 1 , wherein the salt is ammonium sulfate.

9. The method of claim 8 , wherein the ammonium sulfate has a concentration of about 0.8 M to about 1.2 M.

10. The method of claim 9 , wherein prior to the treating, the method comprises the steps of:

a. harvesting a crude fermentation comprising the collagenase; and

b. filtering the crude fermentation over an anion exchange filter.

11. The method of claim 10 , wherein the chromatography comprises hydrophobic interaction chromatography, ion-exchange chromatography, or a combination thereof.

12. The method of claim 1 , wherein the collagenase is derived from Clostridium histolyticum.

Assignments (6)
SECURITY INTEREST Recorded Jul 19, 2024
From: ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 068031/0059 →
SECURITY INTEREST Recorded Jul 19, 2024
From: ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068031/0202 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2024
From: ENDO VENTURES UNLIMITED COMPANY
To: OPERAND PHARMACEUTICALS III LIMITED
Reel/Frame 066732/0137 →
CHANGE OF NAME Recorded Mar 5, 2024
From: ENDO VENTURES LIMITED
To: ENDO VENTURES UNLIMITED COMPANY
Reel/Frame 066732/0396 →
CHANGE OF NAME Recorded Mar 5, 2024
From: OPERAND PHARMACEUTICALS III LIMITED
To: ENDO OPERATIONS LIMITED
Reel/Frame 066732/0413 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2021
From: SHEAFFER, CHRISTINE A.; BERBAUM, MICHAEL; HANNA, JOHN; DZIADOSZ, JASON; SHANAFELT, DANIEL
To: ENDO VENTURES LTD.
Reel/Frame 058469/0096 →